Next Day Disclosure Return
Filed with HKEX · Stock code 2565 · · 6 pages · English
Earlier from PegBio
- Completion of placing of new h shares under general mandate
- Cancellation of extraordinary general meeting and cancellation of book closure period
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Placing of new h shares under general mandate
- Form of proxy for use at the 2026 first extraordinary general meeting to be held on Thursday, November 12, 2026
Later from PegBio
- (1) Proposed removal of auditor (2) proposed appointment of auditor (3) proposed change in use of proceeds from the global offering and (4) notice of the 2026 first extraordinary general meeting
- Notice of the 2026 first extraordinary general meeting
- Form of proxy for use at the 2026 first extraordinary general meeting to be held on Thursday, November 26, 2026
- Voluntary announcement successful inclusion of the group's core product paidakang (visepegenatide injection) into the 2026 NRDL
Follow PegBio into a list and get an email when it puts out news.
Follow PegBio